• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者最佳水合状态的重要性——并非总是液体过多。

The Importance of Optimal Hydration in Patients with Heart Failure-Not Always Too Much Fluid.

作者信息

Wittczak Andrzej, Ślot Maciej, Bielecka-Dabrowa Agata

机构信息

Department of Preventive Cardiology and Lipidology, Medical University of Lodz, 90-419 Lodz, Poland.

Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.

出版信息

Biomedicines. 2023 Sep 30;11(10):2684. doi: 10.3390/biomedicines11102684.

DOI:10.3390/biomedicines11102684
PMID:37893057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10604032/
Abstract

Heart failure (HF) is a leading cause of morbidity and mortality and a major public health problem. Both overhydration and dehydration are non-physiological states of the body that can adversely affect human health. Congestion and residual congestion are common in patients hospitalized for HF and are associated with poor prognosis and high rates of rehospitalization. However, the clinical problem of dehydration is also prevalent in healthcare and community settings and is associated with increased morbidity and mortality. This article provides a comprehensive review of the issue of congestion and dehydration in HF, including HF guidelines, possible causes of dehydration in HF, confirmed and potential new diagnostic methods. In particular, a full database search on the relationship between dehydration and HF was performed and all available evidence in the literature was reviewed. The novel hypothesis of chronic subclinical hypohydration as a modifiable risk factor for HF is also discussed. It is concluded that maintaining euvolemia is the cornerstone of HF management. Physicians have to find a balance between decongestion therapy and the risk of dehydration.

摘要

心力衰竭(HF)是发病和死亡的主要原因,也是一个重大的公共卫生问题。水合过多和脱水都是身体的非生理状态,会对人类健康产生不利影响。充血和残余充血在因HF住院的患者中很常见,并且与预后不良和再住院率高有关。然而,脱水的临床问题在医疗保健和社区环境中也很普遍,并且与发病率和死亡率增加有关。本文全面综述了HF中充血和脱水问题,包括HF指南、HF中脱水的可能原因、已证实和潜在的新诊断方法。特别是,对脱水与HF之间的关系进行了全面的数据库搜索,并对文献中的所有现有证据进行了综述。还讨论了慢性亚临床脱水作为HF可改变危险因素的新假说。结论是维持正常血容量是HF管理的基石。医生必须在解除充血治疗和脱水风险之间找到平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/b0357d11d9f8/biomedicines-11-02684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d27423a90ed2/biomedicines-11-02684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/98c765a3a233/biomedicines-11-02684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d2dc8ca84212/biomedicines-11-02684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d0299654f50b/biomedicines-11-02684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/0bb826750003/biomedicines-11-02684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/b0357d11d9f8/biomedicines-11-02684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d27423a90ed2/biomedicines-11-02684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/98c765a3a233/biomedicines-11-02684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d2dc8ca84212/biomedicines-11-02684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/d0299654f50b/biomedicines-11-02684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/0bb826750003/biomedicines-11-02684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdf/10604032/b0357d11d9f8/biomedicines-11-02684-g006.jpg

相似文献

1
The Importance of Optimal Hydration in Patients with Heart Failure-Not Always Too Much Fluid.心力衰竭患者最佳水合状态的重要性——并非总是液体过多。
Biomedicines. 2023 Sep 30;11(10):2684. doi: 10.3390/biomedicines11102684.
2
The Added Value of In-Hospital Tracking of the Efficacy of Decongestion Therapy and Prognostic Value of a Wearable Thoracic Impedance Sensor in Acutely Decompensated Heart Failure With Volume Overload: Prospective Cohort Study.住院期间对充血性心力衰竭治疗效果进行跟踪的附加价值以及可穿戴式胸阻抗传感器在急性失代偿性心力衰竭伴容量超负荷中的预后价值:前瞻性队列研究
JMIR Cardio. 2020 Mar 18;4(1):e12141. doi: 10.2196/12141.
3
Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.增强型体外反搏(EECP):基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.
4
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.生物活性肾上腺髓质素作为急性心力衰竭住院患者残留充血和早期再入院的标志物:STRONG-HF 研究数据。
Eur J Heart Fail. 2024 Jul;26(7):1480-1492. doi: 10.1002/ejhf.3336. Epub 2024 Jun 14.
5
Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry.因失代偿性心力衰竭住院患者临床充血严重程度的预后价值:来自日本 KCHF 登记处的结果。
J Card Fail. 2023 Aug;29(8):1150-1162. doi: 10.1016/j.cardfail.2023.01.003. Epub 2023 Jan 21.
6
The Congestion "Pandemic" in Acute Heart Failure Patients.急性心力衰竭患者的充血“大流行”
Biomedicines. 2024 Apr 24;12(5):951. doi: 10.3390/biomedicines12050951.
7
Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study.与心力衰竭患者住院期间静脉利尿相比,呋塞米利辛可降低心力衰竭相关的医疗保健费用:FREEDOM-HF 研究。
Future Cardiol. 2023 Jun;19(8):385-396. doi: 10.2217/fca-2023-0071. Epub 2023 Aug 23.
8
Bioimpedance to prevent heart failure hospitalization.生物阻抗预防心力衰竭住院
Curr Heart Fail Rep. 2006 Sep;3(3):136-42. doi: 10.1007/s11897-006-0013-y.
9
The use of the reds noninvasive lung fluid monitoring system to assess readiness for discharge in patients hospitalized with acute heart failure: A pilot study.应用 Reds 无创性肺液监测系统评估急性心力衰竭住院患者的出院准备情况:一项试点研究。
Heart Lung. 2021 Jan-Feb;50(1):59-64. doi: 10.1016/j.hrtlng.2020.07.003. Epub 2020 Jul 20.
10
Efficacy of Rapid Decongestion Strategy in Patients Hospitalized for Acute Heart Failure.急性心力衰竭住院患者快速消肿策略的疗效。
Circ J. 2020 May 25;84(6):958-964. doi: 10.1253/circj.CJ-19-1128. Epub 2020 Apr 21.

引用本文的文献

1
Hydration Strategies in Older Adults.老年人的水合作用策略
Nutrients. 2025 Jul 8;17(14):2256. doi: 10.3390/nu17142256.
2
Exploring Neurohormonal Modulation by Acetazolamide in Heart Failure.探索乙酰唑胺对心力衰竭的神经激素调节作用。
Cureus. 2024 Dec 16;16(12):e75786. doi: 10.7759/cureus.75786. eCollection 2024 Dec.
3
Nutritional and Nutraceutical Support to the Failing Myocardium: A Possible Way of Potentiating the Current Treatment of Heart Failure.营养与营养支持治疗衰竭心肌:增强心力衰竭现行治疗的可能途径。

本文引用的文献

1
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
2
Sodium-glucose cotransporter-2 inhibitors in heart failure: Potential decongestive mechanisms and current clinical studies.钠-葡萄糖共转运蛋白 2 抑制剂在心力衰竭中的应用:潜在的利尿机制和当前的临床研究。
Eur J Heart Fail. 2023 Sep;25(9):1526-1536. doi: 10.1002/ejhf.2967. Epub 2023 Jul 26.
3
Falling corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis.
Int J Mol Sci. 2024 Nov 14;25(22):12232. doi: 10.3390/ijms252212232.
4
Fluid Restriction for Patients with Heart Failure: Current Evidence and Future Perspectives.心力衰竭患者的液体限制:当前证据与未来展望
J Pers Med. 2024 Jul 11;14(7):741. doi: 10.3390/jpm14070741.
5
Impact of homeostatic body hydration status, evaluated by hemodynamic measures, on different pain sensitization paths to a chronic pain syndrome.基于血流动力学指标评估的体内稳态水合状态对不同慢性疼痛综合征敏化途径的影响。
Sci Rep. 2024 Jan 22;14(1):1908. doi: 10.1038/s41598-024-52419-3.
Corin和心房钠尿肽(ANP)活性水平下降会加速心力衰竭和心脏纤维化的发展。
Front Cardiovasc Med. 2023 Apr 18;10:1120487. doi: 10.3389/fcvm.2023.1120487. eCollection 2023.
4
The GLVC scoring system: a single-center model for predicting survival and hospitalization in patients with heart failure.GLVC 评分系统:一种用于预测心力衰竭患者生存和住院情况的单中心模型。
Ir J Med Sci. 2023 Dec;192(6):2713-2726. doi: 10.1007/s11845-023-03343-4. Epub 2023 Apr 12.
5
Diagnosing Lung Abnormalities Related to Heart Failure in Chest Radiogram, Lung Ultrasound and Thoracic Computed Tomography.诊断与心力衰竭相关的胸部放射影像、肺部超声和胸部计算机断层扫描中的肺部异常。
Adv Respir Med. 2023 Feb 23;91(2):103-122. doi: 10.3390/arm91020010.
6
Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease.慢性肾脏病心力衰竭患者尿素氮分数排泄率的应用。
ESC Heart Fail. 2023 Jun;10(3):1706-1716. doi: 10.1002/ehf2.14327. Epub 2023 Feb 23.
7
A review of bio-impedance devices.生物阻抗设备综述。
Med Biol Eng Comput. 2023 May;61(5):927-950. doi: 10.1007/s11517-022-02763-1. Epub 2023 Jan 13.
8
Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction.新冠病毒感染后左心室射血分数正常患者持续运动耐量受限的因素
Biomedicines. 2022 Dec 15;10(12):3257. doi: 10.3390/biomedicines10123257.
9
The National Early Warning Score: from concept to NHS implementation.国家早期预警评分:从概念到 NHS 的实施。
Clin Med (Lond). 2022 Nov;22(6):499-505. doi: 10.7861/clinmed.2022-news-concept.
10
A Current Review of the Uses of Bioelectrical Impedance Analysis and Bioelectrical Impedance Vector Analysis in Acute and Chronic Heart Failure Patients: An Under-valued Resource?生物电阻抗分析和生物电阻抗向量分析在急性和慢性心力衰竭患者中的应用:被低估的资源?
Biol Res Nurs. 2023 Apr;25(2):240-249. doi: 10.1177/10998004221132838. Epub 2022 Nov 7.